---
title: "MDCX.US (MDCX.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/MDCX.US/news.md"
symbol: "MDCX.US"
name: "MDCX.US"
parent: "https://longbridge.com/en/quote/MDCX.US.md"
datetime: "2026-05-22T00:20:22.008Z"
locales:
  - [en](https://longbridge.com/en/quote/MDCX.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/MDCX.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/MDCX.US/news.md)
---

# MDCX.US (MDCX.US) — Related News

### [](https://longbridge.com/en/news/285403232.md)
*2026-05-06T15:08:30.000Z*
> Medicus Pharma shares are trading higher after the company announced results from pre-specified expanded Phase 2 SKNJCT-

### [EXCLUSIVE: Medicus Sees Strongest Efficacy At Higher Dose In Skin Cancer Study](https://longbridge.com/en/news/285368052.md)
*2026-05-06T11:17:16.000Z*
> Medicus Pharma Ltd. reported strong efficacy results in its Phase 2 study for Doxorubicin Microneedle Array (D-MNA) in t

### [12 Health Care Stocks Moving In Monday's Pre-Market Session](https://longbridge.com/en/news/284214245.md)
*2026-04-27T12:05:45.000Z*
> In Monday's pre-market session, Onconetix (NASDAQ:ONCO) shares surged 39.8% to $0.82, while Sagimet Biosciences (NASDAQ:

### [Medicus Pharma Disclosed Failure to Satisfy a Continued Listing Rule or Standard](https://longbridge.com/en/news/284057186.md)
*2026-04-24T21:33:01.000Z*
> Medicus Pharma has disclosed that it failed to meet Nasdaq's continued listing requirement due to its shares not maintai

### [Medicus Pharma Upsizes ATM Program to $50 Million With Maxim Group and Yorkville Securities](https://longbridge.com/en/news/284057169.md)
*2026-04-24T21:33:01.000Z*
> Medicus Pharma has amended its Equity Distribution Agreement to increase its at-the-market (ATM) equity offering capacit

### [Medicus Pharma Submits Orphan Drug Designation Application to U.S. FDA for SkinJect® in Gorlin Syndrome | MDCX Stock News](https://longbridge.com/en/news/283136485.md)
*2026-04-17T03:30:50.000Z*
> Medicus Pharma Submits Orphan Drug Designation Application to U.S. FDA for SkinJect® in Gorlin Syndrome | MDCX Stock New

### [12 Health Care Stocks Moving In Wednesday's Pre-Market Session](https://longbridge.com/en/news/282843645.md)
*2026-04-15T12:05:43.000Z*
> In Wednesday's pre-market session, Immutep (NASDAQ:IMMP) saw a significant gain of 135.4%, reaching $0.74, with a market

### [EXCLUSIVE: Penny Stock Medicus Pharma Findings Support Potential In Women's Health Pipeline](https://longbridge.com/en/news/282836614.md)
*2026-04-15T11:16:06.000Z*
> Medicus Pharma Ltd. (NASDAQ:MDCX) will present Phase 1 clinical data for its investigational therapy Teverelix at the AA